Clinical Trials Browser

Hematologic Neoplasms × tanespimycin × Plasma cell × Clear all

NCT00113204 2008-05-20

IPi-504-01

Phase 1 Completed

Other hematologic neoplasmPlasma cell

Hematologic Diseases, Multiple Myeloma, Recurrence, Hematologic Neoplasms